News

What Makes Legend Biotech (LEGN) a New Buy Stock
Legend Biotech (LEGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Evergy to release Q1 earnings: Here's what you need to know
AEP’s long-term (three to five years) earnings growth rate is 6.43%. The Zacks Consensus Estimate for earnings is pinned at ...
DuPont de Nemours (DD) tops Q1 earnings and revenue estimates
DuPont de Nemours came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.95 per ...
Zacks Investment Research on MSN5h
KLA (KLAC) Upgraded to Buy: Here's Why
KLA (KLAC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...
Zacks.com on MSN8h
Advanced Micro Devices, Inc. (AMD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Advanced Micro (AMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks Investment Research on MSN5h
Surging Earnings Estimates Signal Upside for South Plains Financial (SPFI) Stock
South Plains Financial (SPFI) could be a solid addition to your portfolio given a notable revision in the company's earnings ...